Cargando…
Gene Therapy in a Humanized Mouse Model of Familial Hypercholesterolemia Leads to Marked Regression of Atherosclerosis
BACKGROUND: Familial hypercholesterolemia (FH) is an autosomal codominant disorder caused by mutations in the low-density lipoprotein receptor (LDLR) gene. Homozygous FH patients (hoFH) have severe hypercholesterolemia leading to life threatening atherosclerosis in childhood and adolescence. Mice wi...
Autores principales: | Kassim, Sadik H., Li, Hui, Vandenberghe, Luk H., Hinderer, Christian, Bell, Peter, Marchadier, Dawn, Wilson, Aisha, Cromley, Debra, Redon, Valeska, Yu, Hongwei, Wilson, James M., Rader, Daniel J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957433/ https://www.ncbi.nlm.nih.gov/pubmed/20976059 http://dx.doi.org/10.1371/journal.pone.0013424 |
Ejemplares similares
-
Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia
por: Sharifi, Mahtab, et al.
Publicado: (2017) -
Correlating corneal arcus with atherosclerosis in familial hypercholesterolemia
por: Zech, Loren A, et al.
Publicado: (2008) -
Familial hypercholesterolemia supravalvular aortic stenosis and extensive atherosclerosis
por: Prajapati, Rajpal, et al.
Publicado: (2018) -
Effects of castration on atherosclerosis in Yucatan minipigs with genetic hypercholesterolemia
por: Shim, Jeong T., et al.
Publicado: (2020) -
The History of the WHHL Rabbit, an Animal Model of Familial Hypercholesterolemia (II): - Contribution to the Development and Validation of the Therapeutics for Hypercholesterolemia and Atherosclerosis -
por: Shiomi, Masashi
Publicado: (2020)